GSK said it will use its established manufacturing network in Belgium to support production. The companies will also work together to research, develop and manufacture several mRNA vaccine ...
GSK has made another investment in its manufacturing ... unveiled plans to build a $270 million-plus vaccines facility in Belgium. Neurotech Pharma's cell therapy Encelto has become the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback